This can be a contributing factor to the benefits of empagliflozin in improving cerebrovascular flow, and may also be a promising avenue for other benefits related to the improvement of depressive symptoms in patients with MDD [37] Moreover, other animal studies have highlighted the role of Nrf2-mediated antioxidants in the prevention of depression [38, 39]. This evidence concerns the gene NFE2L2 and major depressive disorder.